121 STOMP: Small cell lung cancer trial of olaparib (AZD2281) as maintenance programme - a randomised, double blind, multicentre NCRN phase II trial

Lung Cancer ◽

10.1016/s0169-5002(11)70121-0 ◽

2011 ◽

Vol 71 ◽

pp. S42 ◽

Author(s):

P.J. Woll ◽

H. Jarrett ◽

L. Billingham

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Double Blind ◽

Cancer Trial ◽

Maintenance Programme

Download Full-text

A randomized double-blind phase II trial evaluating maintenance PARP inhibitor Olaparib versus placebo in patients with platinum-sensitive advanced non-small cell lung cancer: PIPSeN trial

Annals of Oncology ◽

10.1093/annonc/mdx380.082 ◽

2017 ◽

Vol 28 ◽

pp. v494

Author(s):

S. Postel-Vinay ◽

D. Planchard ◽

A.L. Ortega Granados ◽

A. Gazzah ◽

M.A. Sala Gonzalez ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Parp Inhibitor ◽

Small Cell Lung ◽

Double Blind ◽

Platinum Sensitive

Download Full-text

1791P Effect of anlotinib in advanced small cell lung cancer (SCLC) patients with liver metastases: A subgroup analysis from a randomized, double-blind phase II trial (ALTER 1202)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1552 ◽

2020 ◽

Vol 31 ◽

pp. S1038

Author(s):

Y. Cheng ◽

Q. Wang ◽

K. Li ◽

J. Shi ◽

L. Wu ◽

...

Keyword(s):

Lung Cancer ◽

Liver Metastases ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Subgroup Analysis ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

A randomized double-blind phase II trial of platinum (P) plus etoposide (E) with or without concurrent ZD6474 (Z) in patients (pts) with previously untreated extensive-stage (ES) small cell lung cancer (SCLC): Hoosier Oncology Group LUN06-113.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.7506 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 7506-7506 ◽

Author(s):

Rachel E. Sanborn ◽

Jyoti D. Patel ◽

Gregory A. Masters ◽

Nagesh Jayaram ◽

Anthony W. Stephens ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Small Cell Lung ◽

Double Blind ◽

Extensive Stage

Download Full-text

Abstract LB-77: A randomized double-blind placebo-controlled phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small cell lung cancer: Correlative analyses

10.1158/1538-7445.am10-lb-77 ◽

2010 ◽

Author(s):

David R. Spigel ◽

Howard A. Burris ◽

F. Anthony Greco ◽

Diana L. Shipley ◽

Elke K. Friedman ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Previously Treated

Download Full-text

Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0000000000000037 ◽

2014 ◽

Vol 9 (1) ◽

pp. 126-131 ◽

Author(s):

Pasi A. Jänne ◽

Luis Paz-Ares ◽

Yun Oh ◽

Corinna Eschbach ◽

Vera Hirsh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Cancer Investigation ◽

10.1080/07357900801944856 ◽

2009 ◽

pp. 1-1

Author(s):

A. R. Jazieh ◽

R. Komrokji ◽

A. Gupta ◽

S. Patil ◽

D. Flora ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text

P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.875 ◽

2021 ◽

Vol 16 (3) ◽

pp. S501

Author(s):

P. Deng ◽

H. Yang ◽

C. Chen ◽

C. Hu ◽

L. Cao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

Small Cell Lung ◽

Extensive Stage

Download Full-text

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.237 ◽

2018 ◽

Vol 13 (10) ◽

pp. S320-S321 ◽

Author(s):

S. Lin ◽

X. Lin ◽

D. Clay ◽

L. Yao ◽

I. Mok ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Chemoradiation Therapy ◽

Small Cell Lung

Download Full-text

Phase II trial of high dose epirubicin and ifosfamide in advanced non small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/0169-5002(91)91763-2 ◽

1991 ◽

Vol 7 ◽

pp. 111

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

High Dose ◽

Small Cell Lung

Download Full-text

Randomized Phase II Trial of Sequential Chemotherapy in Advanced Non-Small Cell Lung Cancer (SWOG 9806)

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-0002 ◽

2004 ◽

Vol 10 (15) ◽

pp. 5022-5026 ◽

Author(s):

Martin J. Edelman ◽

Joseph I. Clark ◽

Kari Chansky ◽

Kathy Albain ◽

Nirmala Bhoopalam ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Sequential Chemotherapy ◽

Randomized Phase Ii

Download Full-text